Westlake Corp 8-K Summary: Board Appointments
Business Context and Reporting Period
This Form 8-K, dated January 5, 2018, reports corporate governance changes for Westlake Chemical Corporation. The filing details the appointment of three new directors to the Board of Directors as part of the company's long-term succession planning.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed relates to director compensation: each new director received a grant of restricted stock units valued at $120,000 based on the grant date fair value.
Material Changes
The primary material change is the expansion of the Board of Directors with the following appointments:
- Jeffrey Sheets: Appointed as a Class I director (term expires 2020). Former Executive Vice President and CFO of ConocoPhillips.
- Marius Haas: Appointed as a Class I director (term expires 2020). Former President and Chief Commercial Officer of Dell EMC.
- David Chao: Appointed as a Class III director (term expires 2019). Former Vice President of Business Development for Asia and Middle East at Westlake and current Executive Chairman of Tanglewood Property Group.
All three directors are expected to serve on the Compensation, Corporate Risk, and Nominating and Governance Committees. Mr. Sheets and Mr. Haas will also serve on the Audit Committee.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of operational risks. It notes that Mr. David Chao is related to existing company leadership (son of James Chao, nephew of Albert Chao and Dorothy C. Jenkins). No other reportable transactions or relationships under Item 404(a) of Regulation S-K were identified beyond those previously disclosed in the 2017 Proxy Statement.
Investor Verification Checklist
- Verify the vesting schedule for the $120,000 restricted stock unit grants (vests on the first anniversary of the grant date).
- Review the attached press release (Exhibit 99.1) for additional context on the strategic rationale for these appointments.
- Confirm the updated Board composition and committee assignments in subsequent filings.
- Note that this filing does not impact the company's financial statements or operational results.